Descripción del proyecto
Solubilidad sostenible para los sectores farmacéutico y químico
Medir la solubilidad es un proceso necesario pero laborioso que suele requerir grandes cantidades de sustancias químicas. Los métodos actuales son rápidos pero imprecisos o lentos pero precisos. En ambos casos, es necesario emplear muchas sustancias químicas. Teniendo esto en cuenta, el proyecto FASS, financiado por el Consejo Europeo de Innovación, ofrece una solución tecnológica sostenible a estos inconvenientes para los sectores farmacéutico y químico. La tecnología utiliza la dispersión de segundo armónico de alta eficiencia, que combina las ventajas analíticas de las mediciones de solubilidad actuales con un rendimiento rápido y preciso, sensibilidad de vanguardia y fiabilidad. Esta innovación ahorra un 90 % de costes, acorta en un 90 % el tiempo de medición, disminuye en un 99 % el uso de sustancias químicas, reduce en un 97 % el consumo de electricidad y limita en un 80 % el número de compuestos utilizados en comparación con los métodos de referencia.
Objetivo
Solubility measurement is a standard test that is required for every chemical that is produced or tested. However, measuring solubility is a time/labour-intensive process that requires substantial quantities of chemicals. State-of-the-Art solubility measurements are either fast but inaccurate or slow but accurate and require excess of chemicals. FASS is based on high-efficiency second harmonic scattering that combines the analytical advantages of current solubility measurements, fast and accurate, while achieving cutting edge performance in sensitivity and reliability. FASS saves 90% of cost, 90% of measurement time, 99% of chemicals and 97% of electricity and 80% of compounds compared to the gold standard. As an optical light scattering technique, FASS is non-destructive, and combined with analytical advantages and sustainable use of chemicals and compounds, provides a disruptive innovation in solubility measurement. The consortium is composed of a dedicated startup to bring the instrument to market, a research and technology organization to support technology maturation, a European Research Consortium to enable customer development and instrument demonstration and a center for pharmaceutical research to explore value-added applications of FASS in drug discovery and development. The goals of the project are: 1) to develop a demonstrator with optimized and robust performance suited for instrument demonstration and application exploration. 2) to validate the technology with early adopters in early stage drug discovery and development and chemical synthesis companies. 3) to develop a feasible business model and go-to-market strategy to be implemented by the startup. FASS brings a sustainable solution to the pharmaceutical and chemical industries, reduce chemical and electrical consumption, and through a dedicated startup, will create jobs, foster competition and contribute to the growth of the pharmaceutical industry and the European economy.
Palabras clave
Programa(s)
- HORIZON.3.1 - The European Innovation Council (EIC) Main Programme
Convocatoria de propuestas
HORIZON-EIC-2023-TRANSITION-01
Consulte otros proyectos de esta convocatoriaRégimen de financiación
HORIZON-EIC - HORIZON EIC GrantsCoordinador
13125 Berlin
Alemania